Folate supplement for fatty liver disease
Part of Digestive system clinical trials.
This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have been diagnosed with mild to moderate fatty liver (grade 1 or 2 on ultrasound)
- Your body mass index (BMI) is between 25 and 34.9
- You are not pregnant, breastfeeding, or planning pregnancy in the next three months
- You do not have other liver diseases, diabetes, or serious health conditions
- You are not taking certain medications like metformin, methotrexate, or folate supplements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special supplement (made from cacao, nopal, and crickets) can help improve fatty liver disease in people with excess body fat. Fatty liver disease happens when fat builds up in the liver, and this trial investigates whether these natural ingredients can reduce that buildup.
This study tests whether a combination of rutin (a plant compound) and vitamin C can help people with fatty liver disease (MASLD). If you have MASLD and no other serious liver conditions, this trial may be a good fit.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether aspirin can help people with MASLD, a type of fatty liver disease linked to conditions like diabetes and obesity. It aims to see if aspirin can improve liver health without causing harm.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This trial studies whether LivPhcD capsules can improve fatty liver disease and checks for side effects. It may help people with non-alcohol-related fatty liver disease who meet specific liver-scanning and lab results.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.